MétaCan
Menu
Back to cohort
Record W4394933306 · doi:10.2967/jnumed.123.267014

Development of a Visually Calculated SUV<sub>mean</sub>(HIT Score) on Screening PSMA PET/CT to Predict Treatment Response to<sup>177</sup>Lu-PSMA Therapy: Comparison with Quantitative SUV<sub>mean</sub>and Patient Outcomes

2024· article· en· W4394933306 on OpenAlexaff
Mina Swiha, Nathan Papa, Zahra Sabahi, Narjess Ayati, Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker, Sherrington Li, Shikha Agrawal, Maria Ayers, Adam Hickey, Shikha Sharma, Andrew Nguyen, Louise Emmett

Bibliographic record

VenueJournal of Nuclear Medicine · 2024
Typearticle
Languageen
FieldMedicine
TopicProstate Cancer Treatment and Research
Canadian institutionsWestern University
Fundersnot available
KeywordsProstate cancerGlutamate carboxypeptidase IIMedicineNuclear medicineTaxaneStandardized uptake valueProstateCancerPositron emission tomographyInternal medicineBreast cancer

Abstract

fetched live from OpenAlex

<sup>177</sup>Lu-PSMA therapy is an effective treatment in patients with metastatic castration-resistant prostate cancer. SUV<sub>mean</sub> is a valuable screening biomarker to assess the suitability for <sup>177</sup>Lu-PSMA therapy but requires quantitative software. This study aims to develop a simple, clinically applicable prostate-specific membrane antigen PET/CT score that encompasses the elements of SUV<sub>mean</sub> without requiring additional quantification. <b>Methods:</b> Datasets from ethics-approved trials of patients with metastatic castration-resistant prostate cancer after androgen receptor signaling inhibition and taxane chemotherapy (or unfit for taxane), who were treated with <sup>177</sup>Lu-PSMA-617 and <sup>177</sup>Lu-PSMA I&amp;T with a pretreatment screening with <sup>68</sup>Ga-PSMA-11 PET/CT, and clinical outcome data, including a prostate-specific antigen (PSA) 50% response rate (PSA50), PSA progression-free survival (PSA-PFS), and overall survival (OS), were included. The screening <sup>68</sup>Ga-PSMA-11 PET/CT of all participants was analyzed both semiquantitatively and visually. Semiquantitative analysis was used to derive the SUV<sub>mean</sub>. Visual analysis of the <sup>68</sup>Ga-PSMA-11 PET/CT images involved a binary visual heterogeneity assessment (homogeneous or heterogeneous), allocating a tumor SUV<sub>max</sub> range (&lt;15, 15–29, 30–49, 50–79, or ≥80). A 4-category score incorporating both heterogeneity and intensity of tumors (HIT) was then developed as a combination of heterogeneity and intensity (SUV<sub>max</sub> range). The SUV<sub>max</sub> was less than 15 for score 1, 15–79 with heterogeneous intensity for score 2, 15–79 with homogeneous intensity for score 3, and 80 or greater for score 4. This score was evaluated according to clinical outcomes (PSA50, PSA-PFS, and OS) and compared with SUV<sub>mean</sub>. <b>Results:</b> Data from 139 participants were analyzed. In total, 75 (54%) patients achieved a PSA50 with a median PSA-PFS of 5.5 mo (95% CI, 4.1–6.0 mo) and an OS of 13.5 mo (95% CI, 11.1–17.9 mo). SUV<sub>mean</sub> was associated with PSA50 and survival outcomes when analyzed as a continuous variable or as quartiles. The PSA50 for HIT scores 1–4 was 0%, 39%, 65%, and 76%, respectively. The HIT score was strongly related to PSA-PFS and OS (log-rank test, <i>P</i> &lt; 0.001 and <i>P</i> = 0.002). The median PSA-PFS for HIT scores 1–4 was 1.0, 4.1, 6.0, and 8.5, respectively, and the median OS was 7.6, 12.0, 18.5, and 16.9 mo, respectively. Cohen κ between readers for the HIT score was 0.71. <b>Conclusion:</b> A prostate-specific membrane antigen PET/CT score incorporating HIT derived from tools on a standard PET workstation is comparable with quantitative SUV<sub>mean</sub> as a prognostic tool following <sup>177</sup>Lu-PSMA therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.234
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.060
GPT teacher head0.358
Teacher spread0.298 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations25
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Nuclear MedicineSame topicProstate Cancer Treatment and ResearchFrench-language works237,207